2024-12-19 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

**1. Performance Comparison and Divergence:**

Intuitive Surgical Inc. (ISRG) is a company that manufactures and sells da Vinci surgical systems and related instruments and accessories.

The cumulative return of ISRG is 286.34%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 114.36%.  The difference is 172.0%, placing it at the 91.6th percentile of its historical performance relative to the S&P 500.  This indicates ISRG has historically outperformed the benchmark significantly over the period considered.  The provided alpha values of 0.0 suggest that the outperformance is not entirely attributable to systematic market risk (beta).


**2. Recent Price Movement:**

* **Closing Price:** $526.47
* **5-day Moving Average:** $539.58
* **20-day Moving Average:** $542.53
* **60-day Moving Average:** $517.34

The stock is currently trading below its 5-day and 20-day moving averages, suggesting a recent downward trend.  However, it is above its 60-day moving average, indicating potential support.


**3. Technical Indicators and Expected Return:**

* **RSI (Relative Strength Index):** 40.99 – This indicates the stock is approaching oversold territory, suggesting potential for a bounce.
* **PPO (Price Oscillator):** -0.49 –  A negative PPO value suggests bearish momentum.
* **Recent Relative Divergence:** -2.4% – Shows a recent downward trend in relative strength.
* **Expected Return (2+ years):** 111.0% – This represents a significant projected outperformance compared to the S&P 500 over the long term, assuming continued historical trends.  However, this is not guaranteed and depends heavily on future market conditions and company performance.  The high expected return is consistent with the historical outperformance against the S&P 500.  The current price of $526.47 near the 60 day moving average doesn't suggest an immediate significant upside or downside based purely on this analysis.

**4. Recent Earnings Analysis:**

The provided earnings data shows a generally upward trend in both revenue and EPS, although there is some fluctuation.  Revenue consistently increased quarter over quarter except for the slight dip from Q2 2024 to Q3 2024.   EPS shows relatively stable performance, with only minor changes between quarters. There is no information available regarding whether any of these results beat or missed expectations. Further information is required to draw more detailed conclusions.  Note the duplication of the 2024-10-18 entry in the data provided.

**5. Financial Information Analysis:**

* **Revenue:** Shows consistent growth, with some minor fluctuations.
* **Profit Margin:** Remains relatively stable and high, averaging around 67%, indicating strong profitability.
* **Equity:** Steadily increasing, demonstrating growth in the company's net worth.
* **ROE (Return on Equity):** Shows some fluctuations but is generally positive, indicating reasonable returns on shareholder equity, although there is a slight downtrend.

**6. News and Recent Issues:**

No news or recent market outlook information was provided to be analyzed.  Analyst opinions and performance highlights were also not supplied. Information is needed from current news and financial sites.

**7. Overall Analysis:**

ISRG has historically demonstrated strong performance relative to the S&P 500, indicated by its high cumulative return and significant positive divergence.  Recent price action suggests a short-term downward trend, while technical indicators suggest potential for a bounce.  However, this should be viewed cautiously. The company’s financial health appears strong, with consistent revenue growth and high profit margins.  Long-term prospects seem promising based on the high projected expected return.  However, investors should exercise caution due to uncertainty about future market performance and the lack of further news and analyst information.  The analysis is limited by the missing data points in the provided information.


**8. Disclaimer:** This analysis is based solely on the provided data and should not be considered financial advice.  Conduct thorough independent research and consult with a financial advisor before making any investment decisions.  The accuracy and completeness of the provided data is assumed but not verified.
